The immunobiology of apotransferrin in type 1 diabetes

K. Mangano, P. Fagone, M. Di Mauro, E. Ascione, V. Maiello, T. Milicic, A. Jotic, N. M. Lalic, T. Saksida, I. Stojanovic, C. Selmi, C. Farina, S. Stosic-Grujicic, P. Meroni, F. Nicoletti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The transferrin (Tf) family of iron binding proteins includes important endogenous modulators of the immune function that may modulate autoimmune diseases. To define more clearly the role of apotransferrin (apoTf) in type 1 diabetes we determined the impact of this protein on type 1 diabetes as investigated in islet cells, animal models and patient sera. First, we demonstrated that recombinant apoTf counteracts the cytokine-induced death of murine pancreatic islet cells. Secondly, human apoTf administration favourably influences the course of type 1 diabetes in animal models, resulting in protection against disease development that was associated with reduction of insulitis and reduced levels of proinflammatory cytokines. Finally, we confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long-lasting disease. In conclusion, our data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.

Original languageEnglish (US)
Pages (from-to)244-252
Number of pages9
JournalClinical and Experimental Immunology
Volume169
Issue number3
DOIs
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Islets of Langerhans
Animal Models
Iron-Binding Proteins
Cytokines
Transferrin
Serum
Autoimmune Diseases
apotransferrin
Pathology
Proteins

Keywords

  • Biomarker
  • Insulitis
  • Iron
  • NOD

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Mangano, K., Fagone, P., Di Mauro, M., Ascione, E., Maiello, V., Milicic, T., ... Nicoletti, F. (2012). The immunobiology of apotransferrin in type 1 diabetes. Clinical and Experimental Immunology, 169(3), 244-252. https://doi.org/10.1111/j.1365-2249.2012.04619.x

The immunobiology of apotransferrin in type 1 diabetes. / Mangano, K.; Fagone, P.; Di Mauro, M.; Ascione, E.; Maiello, V.; Milicic, T.; Jotic, A.; Lalic, N. M.; Saksida, T.; Stojanovic, I.; Selmi, C.; Farina, C.; Stosic-Grujicic, S.; Meroni, P.; Nicoletti, F.

In: Clinical and Experimental Immunology, Vol. 169, No. 3, 09.2012, p. 244-252.

Research output: Contribution to journalArticle

Mangano, K, Fagone, P, Di Mauro, M, Ascione, E, Maiello, V, Milicic, T, Jotic, A, Lalic, NM, Saksida, T, Stojanovic, I, Selmi, C, Farina, C, Stosic-Grujicic, S, Meroni, P & Nicoletti, F 2012, 'The immunobiology of apotransferrin in type 1 diabetes', Clinical and Experimental Immunology, vol. 169, no. 3, pp. 244-252. https://doi.org/10.1111/j.1365-2249.2012.04619.x
Mangano K, Fagone P, Di Mauro M, Ascione E, Maiello V, Milicic T et al. The immunobiology of apotransferrin in type 1 diabetes. Clinical and Experimental Immunology. 2012 Sep;169(3):244-252. https://doi.org/10.1111/j.1365-2249.2012.04619.x
Mangano, K. ; Fagone, P. ; Di Mauro, M. ; Ascione, E. ; Maiello, V. ; Milicic, T. ; Jotic, A. ; Lalic, N. M. ; Saksida, T. ; Stojanovic, I. ; Selmi, C. ; Farina, C. ; Stosic-Grujicic, S. ; Meroni, P. ; Nicoletti, F. / The immunobiology of apotransferrin in type 1 diabetes. In: Clinical and Experimental Immunology. 2012 ; Vol. 169, No. 3. pp. 244-252.
@article{f4fd7a4b33d44fd8be5e49a203d651d5,
title = "The immunobiology of apotransferrin in type 1 diabetes",
abstract = "The transferrin (Tf) family of iron binding proteins includes important endogenous modulators of the immune function that may modulate autoimmune diseases. To define more clearly the role of apotransferrin (apoTf) in type 1 diabetes we determined the impact of this protein on type 1 diabetes as investigated in islet cells, animal models and patient sera. First, we demonstrated that recombinant apoTf counteracts the cytokine-induced death of murine pancreatic islet cells. Secondly, human apoTf administration favourably influences the course of type 1 diabetes in animal models, resulting in protection against disease development that was associated with reduction of insulitis and reduced levels of proinflammatory cytokines. Finally, we confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long-lasting disease. In conclusion, our data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.",
keywords = "Biomarker, Insulitis, Iron, NOD",
author = "K. Mangano and P. Fagone and {Di Mauro}, M. and E. Ascione and V. Maiello and T. Milicic and A. Jotic and Lalic, {N. M.} and T. Saksida and I. Stojanovic and C. Selmi and C. Farina and S. Stosic-Grujicic and P. Meroni and F. Nicoletti",
year = "2012",
month = "9",
doi = "10.1111/j.1365-2249.2012.04619.x",
language = "English (US)",
volume = "169",
pages = "244--252",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The immunobiology of apotransferrin in type 1 diabetes

AU - Mangano, K.

AU - Fagone, P.

AU - Di Mauro, M.

AU - Ascione, E.

AU - Maiello, V.

AU - Milicic, T.

AU - Jotic, A.

AU - Lalic, N. M.

AU - Saksida, T.

AU - Stojanovic, I.

AU - Selmi, C.

AU - Farina, C.

AU - Stosic-Grujicic, S.

AU - Meroni, P.

AU - Nicoletti, F.

PY - 2012/9

Y1 - 2012/9

N2 - The transferrin (Tf) family of iron binding proteins includes important endogenous modulators of the immune function that may modulate autoimmune diseases. To define more clearly the role of apotransferrin (apoTf) in type 1 diabetes we determined the impact of this protein on type 1 diabetes as investigated in islet cells, animal models and patient sera. First, we demonstrated that recombinant apoTf counteracts the cytokine-induced death of murine pancreatic islet cells. Secondly, human apoTf administration favourably influences the course of type 1 diabetes in animal models, resulting in protection against disease development that was associated with reduction of insulitis and reduced levels of proinflammatory cytokines. Finally, we confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long-lasting disease. In conclusion, our data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.

AB - The transferrin (Tf) family of iron binding proteins includes important endogenous modulators of the immune function that may modulate autoimmune diseases. To define more clearly the role of apotransferrin (apoTf) in type 1 diabetes we determined the impact of this protein on type 1 diabetes as investigated in islet cells, animal models and patient sera. First, we demonstrated that recombinant apoTf counteracts the cytokine-induced death of murine pancreatic islet cells. Secondly, human apoTf administration favourably influences the course of type 1 diabetes in animal models, resulting in protection against disease development that was associated with reduction of insulitis and reduced levels of proinflammatory cytokines. Finally, we confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long-lasting disease. In conclusion, our data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.

KW - Biomarker

KW - Insulitis

KW - Iron

KW - NOD

UR - http://www.scopus.com/inward/record.url?scp=84864754595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864754595&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2249.2012.04619.x

DO - 10.1111/j.1365-2249.2012.04619.x

M3 - Article

C2 - 22861364

AN - SCOPUS:84864754595

VL - 169

SP - 244

EP - 252

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -